Clearline Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.2M | Buy |
|
|||||
|
2025
Q2 | $1.77M | Sell |
|
|||||
|
2025
Q1 | $2.33M | Sell |
|
|||||
|
2024
Q4 | $2.77M | Sell |
|
|||||
|
2024
Q3 | $4.43M | Buy |
|
|||||
|
2024
Q2 | $5.23M | Sell |
|
|||||
|
2024
Q1 | $7.69M | Sell |
|
|||||
|
2023
Q4 | $10.3M | Sell |
|
|||||
|
2023
Q3 | $6.33M | Buy |
|
|||||
|
2023
Q2 | $3.09M | Buy |
|
|||||
|
2023
Q1 | $3.15M | Buy |
|
|||||
|
2022
Q4 | $2.56M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $560K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $315K | Sell |
|
|||||
|
2019
Q1 | $961K | Hold |
|
|||||
|
2018
Q4 | $1.02M | Buy |
|
|||||
|
2018
Q3 | $974K | Buy |
|